Nanozymes are materials at the nanoscale that act like natural enzymes, but they’re more stable and can be tuned to have specific properties. While largely still in the research phase, these tiny catalysts could enable major breakthroughs in diagnostics, therapeutics, sensors, and environmental remediation.
Webinar recap: A patent-based analysis of where pharmaceutical innovation is heading, from diversifying therapeutic modalities and expanding molecular targets to the disease areas where research is accelerating.
Clean energy depends on advances in generation, storage, and recycling. Explore how chemistry and materials science are moving energy technologies from lab to grid.
Polymer science now spans millions of possible sequences and hundreds of billions in market value, making it harder than ever to spot what matters. A new joint report with PetroChina SAMRI maps the emerging topics shaping energy storage, sustainable materials, flexible electronics, and membranes.
Classical accuracy metrics assume one correct answer per question. Language models (LLMs) and agentic AI break that assumption. Learn about evaluation approaches emerging for scientific AI.
Deep eutectic solvents are key innovations for green chemistry. They’re cost-effective, environmentally friendly substances that can be used in drug delivery, wastewater treatment, and environmental clean-up. Researchers are finding new substances that make them more effective.
A first-of-its-kind data analysis of 25 years of published process chemistry reactions, conducted by CAS and Lilly, reveals long-term trends in solvents, catalysts, reaction conditions, and emerging methods at an industrial scale.
Immunotherapy is driving precision oncology, but existing immuno-oncology treatments aren’t effective for every patient. Our review of the translational research landscape reveals which targets and therapies are showing promising results in clinical trials.
2D materials like graphene and carbon nanotubes are revolutionizing materials science, and now MXenes are introducing even greater adaptability and high-performance properties. Find out why MXenes are versatile industrial materials.
Learn how composting has evolved into a precision-engineered bioprocess, and about how aeration, microbial control, materials science, and AI are reshaping the field.
Five years of global pharmaceutical patent data reveal a field in fundamental transition: therapeutic platforms multiplying, molecular targets expanding well beyond traditional proteins, and disease focus shifting toward previously intractable conditions. The patterns show not just where innovation
Aerogels in shin guards, self-powered sensors in jerseys, leucine-tuned recovery protocols, and smarter artificial turf. The science behind today's most-watched sports is moving faster than the players.
As a new Ebola outbreak emerges, research into this devastating disease continues to accelerate. Discover how scientists are developing vaccines and therapeutics while confronting the challenge of sustaining innovation between crises.
Three experts from CAS, the University of Messina, and the Coriell Institute break down how epigenetics has evolved from a niche research area into a clinical force, with 13 FDA-approved drugs, 2,200+ active trials, and a fast-growing diagnostic toolkit reshaping how we detect and treat cancer.
Highlights from a recent CAS Insights webinar on AI in medicinal chemistry. How CAS BioFinder was used to assist in target prediction for bioactive compounds.
For high-performance technologies in power electronics, energy storage, and optoelectronics, semiconductors need to offer performance beyond standard silicon. Wide bandgap semiconductors can handle the high‑voltage, high‑temperature, and high‑frequency conditions of these emerging applications.
Hantavirus, a rodent-borne RNA virus with case fatality rates up to 40%, is reshaping zoonotic disease risk amid environmental change and global mobility.
research.io